<doc>
  <source>MIT</source>
  <date>28/01/2023</date>
  <course>
    <course_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/</course_url>
    <course_title>Molecular Biology for the Auditory System</course_title>
    <course_tags>
      <list>Science </list>
      <list>Health and Medicine </list>
      <list>Biology </list>
    </course_tags>
  </course>
  <lectures>
    <lecture>
      <lecture_title>PDF - 3.0 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_genetics_genomics/</lecture_pdf_url>
      <lectureno>5</lectureno>
      <slides>
        <slide>
          <slideno>10</slideno>
          <text>Translocation involving chromosomes 11 and 13</text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>Deletion of end of chromosome 4, causing Wolf-Hirschorn syndrome</text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text>How do heritable DNA mutations occur??
UV exposure
Chemical exposure
Faulty cellular mechanisms</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>See Purves et al., Life: The Science of Biology , 4th Edition, by Sinauer Associates (www.sinauer.com ) and WH Freeman 
(www.whfreeman.com ).The Genetic Code</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text>See: Thompson &amp; Thompson, Genetics in Medicine, 2001VNTRs for a genetic locus</text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>See Ishikiriyama et al., 1989PAX3 at 2q35</text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>Point mutations</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>www.ucl.ac.uk/~ucbhjow/ bmsi/bmsi_6.html</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>DR. GREGOR JOHANN MENDEL 
(1822-1884)</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text>Translocation involving chromosomes 11 and 13</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>Larger Mutations
Inversion of chromosome section. Can 
be benign if no genes are interrupted. 
Can lead to gene discovery.InversionInterchange of two chromosome pieces. 
Can be benign if no genes are 
interrupted. Can lead to gene discovery.TranslocationsCan involve deletion of one to many genes. Large deletions may be visible 
cytogenetically. Phenotype can vary 
from mild to extreme. Many recognized 
syndromes are caused by chromosome 
deletions.Deletions</text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>22</slideno>
          <text>See: Thompson &amp; Thompson, Genetics in Medicine, 2001DNA fingerprints of MZ vs DZ twins using multiple 
VNTRs located throughout the genome</text>
        </slide>
        <slide>
          <slideno>21</slideno>
          <text>See: Thompson &amp; Thompson, Genetics in Medicine, 2001Microsattelite markers in human DNA</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 1.6 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_myosinlecture_ag/</lecture_pdf_url>
      <lectureno>17</lectureno>
      <slides>
        <slide>
          <slideno>4</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>Courtesy of Z Y Chen</text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text>Motor               IQ   MyTH4                      FERM Myo15Myosin 15</text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text>The Usher syndromes
~50% of the deaf blind population has Usher syndrome
 There are at least 11 Usher syndrome loci; 6 genes 
identified to date
 Type 1: profound congenital hearing loss, vestibular 
areflexia, early onset vision loss
 Type 2: congenital sloping hearing loss, normal 
vestibular, 1stor 2nddecade vision loss
 Type 3: progressive hearing loss, varible vestibular and 
vision defects</text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>Model for stereocilia fusion in the absence of 
MYO6 in the snells waltzer mouse.
Self et al., Dev. Biol., 1999, 214;331</text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>Myosins in the inner ear
DFNA17 MYH9DFNB30 MYO3A
Splayed 
sterocilliaUsher 1B, 
DFNA11/B2shaker 1 MYO7A
Short sterocillia, 
actin rodsDFNB3 shaker 2 MYO15Fused 
stereocilliaDFNA22 Snells 
waltzerMYO6MYO1Hair cell defects Human 
diseaseMouse 
mutantGene</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>Courtesy of DP Corey</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>Myosin VIIa
Motor            IQ  CC    MyTH4   FERM  SH3 MyTH4  FERM</text>
        </slide>
        <slide>
          <slideno>27</slideno>
          <text>Additional Readings:
Rayment et al. (1993) Science 261: 50-58
Hasson et al., J. Cell Biol., 1997, 137;1287
Self et al., Dev.  Biol., 1999, 214;331
Hasson et al., J. Cell Biol. , 1997, 137; 1300 , 1287, and 1287
Holme and Steel, Trends in Molec . Med. 7(3) 1 March 2001, Page 13 8
Probst et al., Science, 1998, 280:1444</text>
        </slide>
        <slide>
          <slideno>23</slideno>
          <text>MYO 3A staining in mouse inner and outer hair cells
See Walsh et al., PNAS, 2002, 99;7518</text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text>Myosin VIIa and Human Deafness
variable none post-
lingualmoderate DFNA11variable none congenital profound DFNB2absent retinitis
pigmentosacongenital profound USH1BVestibular
FunctionOther
FeaturesOnset Hearing
Loss</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text>The cycle of structural changes 
used by myosin to walk along 
an actin filament (from Alberts et al., 
Molec. Biol. Of the Cell, 2002)</text>
        </slide>
        <slide>
          <slideno>21</slideno>
          <text>Stereocilia of shaker 2 mouse
See Probst et al., Science, 1998, 280:1444</text>
        </slide>
        <slide>
          <slideno>25</slideno>
          <text>MYH9 expression in rat cochlea
See Lalwani et al., Am. J. Hum. Genet., 2000, 67:1121</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text>Myosin VI
Motor            IQ        CC           Globular</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text>Motor            IQ  CC    MyTH4   FERM  SH3 MyTH4  FERM
Motor               IQ   MyTH4                      FERMMyo6, Myo7a, Myo15
Motor            IQ        CC           GlobularMyo6
Myo7a
Myo15</text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text>sh2/sh2
Mouse chromosome 11 ( sh2 )
BAC contig of
sh2 intervalFunctional cloning to rescue the shaker 2 phenotype
}</text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>Myosin VI
Myosin VI Snells Waltzer
130 bp deletionMutations in Myosin VI Producing Deafness</text>
        </slide>
        <slide>
          <slideno>24</slideno>
          <text>DFNA17 kindred and sequence of MYH9
See Lalwani et al., Am. J. Hum. Genet., 2000, 67:1121</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text>Myosin Dimer</text>
        </slide>
        <slide>
          <slideno>22</slideno>
          <text>Progressive hearing loss in DFNB30
See Walsh et al., PNAS, 2002, 99;7518</text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text>Pedigrees and MYO15 allele segregation 
from 3 DFNB3 families
See Wang et al., Science, 1998, 280:1447</text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text>DNA sequence of MYO15 from 3 DFNB3 families
See Wang et al., Science, 1998, 280:1447</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text>Myosin VIIa Tissue Expression
Myosin VIIa is exclusively expressed in:
 retina
 lung kidney testis inner earretinal pigment epithelium
photoreceptor cells
inner hair cells
outer hair cellsHuman Mouse
Human
Human MouseHuman Mouse</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>Courtesy of DP Corey</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>Conventional Myosin
Motor domain
 actin binding
 ATP hydrolysisHead Neck Tail
Colied-coil domain
 dimerization
Regulatory region (IQ)
 light chain bindingN C</text>
        </slide>
        <slide>
          <slideno>26</slideno>
          <text>Hasson et al., J. Cell Biol., 1997, 137;1287</text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>Mutations in Myosin VIIa Producing Deafness
Motor                 IQ  CC    MyTH4  FERM  SH3 MyTH4  FERMUsher 1B mutations
* * ** **** * * ** ** * * *** ******DFNB2 mutations*
#
# #DFNA11 mutations +
+shaker-1 mutations @
@ @ @@ @ @@</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 2.3 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_intro_molec_biol_lect_1/</lecture_pdf_url>
      <lectureno>1</lectureno>
      <slides>
        <slide>
          <slideno>17</slideno>
          <text>Collagen
See www.rcsb.org/pdb/molecules/</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>Amino acids with electically charged side chains: Positive 
See Purves et al., Life: The Science of Biology, 4th Edition, by Sinauer Associates (www.sinauer.com ) and WH Freeman 
(www.whfreeman.com ).</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text>Plasma membrane 
fig.cox.miami.edu/Faculty/ Dana/105F00_4.html</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>From: Molecular 
Biology of the Cell, 
Alberts et al., 4th Ed</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text>www.bio.davidson.edu/courses/ genomics/method/sizes.html</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>The Central Dogma
The Central Dogma</text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>From: Molecular Biology of the Cell, 
Alberts et al., 4th Edition</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>DNA replication</text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>From: Molecular Biology of the 
Cell, Alberts et al., 4th Edition</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>linkage.rockefeller.edu/wli/ gene/dna-rna-protein.jpg</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text>Translation: RNA to Protein</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text>From: Molecular Biology of the Cell, 
Alberts et al., 4th Edition</text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text>Cell Nucleus
Source: http://cellbio.utmb.edu/cellbio/nucleus.htm</text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>The genetic code. See Purves et al., Life: The Science of Biology , 4th Edition, by Sinauer Associates (www.sinauer.com ) and WH 
Freeman (www.whfreeman.com ).</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text>Restriction Enzyme 
See www.rcsb.org/pdb/molecules/</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 1.1 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_development_oct_16_sh/</lecture_pdf_url>
      <lectureno>8</lectureno>
      <slides>
        <slide>
          <slideno>15</slideno>
          <text>Later Development
Asymetric cell division 
Cell signaling: Inductive signal Shh 
Morphogen Shh, BMP 
Lateral Inhibition Notch, Numb 
Cell survival 
and Cell death 
Axonal migration</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>Lateral Inhibition?</text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text>Axons are guided by attraction and repulsion of the growth cone 
&amp; Axonal/Growth cone guidance in the cochlea 
See Alberts et al., 2002 Molecular Biology of the Cell</text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>Later Development 
Asymetric cell division 
Cell signaling:	 Inductive signal 
Morphogen 
Lateral Inhibition 
Cell survival 
Cell death 
Axonal migration</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>Spinal cord cell type induction by morphogenic gradients 
of inducers and inhibitors. 
Source: 
roofplate and 
adjacent cells 
Shh Induction ofDorsal dorsal cell 
types and 
inhibition of 
ventral cell types 
Induction of 
ventral cell 
types and 
inhibition of 
dorsal cell 
typesVentral
Bmp 
Source:
floorplate and
notochord</text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text>Neurotrophic factors are released by 
the neurons targets, bind to receptors, 
and are transported back to the cells 
somae. Neurons that receive trophic 
support survive. Neurons that do not receive sufficient support initiate a 
suicide, also named programmed cell 
death or apoptosis.</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>Blastula --&gt; Gastrulation --&gt; Neurulation --&gt; Later development 
- Ectoderm - CNS 
- Endoderm 
- Mesoderm 
When and where does the ear originate? 
	The first morphological manifestation is a thickening of the 
ectoderm near the hindbrain = otic placode 
	Does this mean that the process starts with placode formation? 
-&gt; check out Groves and Bronner-Fraser (2000)</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text>Motorneurons die during development 
See Alberts et al., 2002 Molecular Biology of the Cell</text>
        </slide>
        <slide>
          <slideno>21</slideno>
          <text>Later Development
Asymetric cell division 
Cell signaling:	 Inductive signal 
Morphogen 
Lateral Inhibition 
Cell survival 
and Cell death 
Axonal migration 
Shh 
Shh, BMP 
Notch, Numb 
Neurotrophins
Attraction and 
repulsion of 
growth cones</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>Cell proliferation 
 Cell specialization 
 Cell interactions 
 Cell movement 
 All these processes happen at once in a developing embryo 
==&gt; To understand basic strategies, we need to narrow our focus</text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>rogre vel or 
c icatepattSequential induction 
Simple pattern 
C is induced by signal 
From B acting on A B A 
P o B C A 
mpl ssi yme D and E are induced by 
Signal from C acting on 
A and B, respectively
d ern 
B D C E A</text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text>Neurotrophins in the inner ear: 
Cochlear hair cells produce BDNF and NT3 as support for auditory 
ganglion neurons. Gene defects in either neurotrophin or their 
appropriate receptors lead to degeneration of auditory ganglion cells.</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text>Gastrulation 
Neurulation 
Later Development 
See Gilbert, Developmental Biology, Sinauer</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text>The result of the Gastrulation is the creation of the three 
germ layers: 
Ectoderm 
Endoderm 
Mesoderm 
Neurulation -&gt;	 the formation of the nervous system from 
the ectoderm</text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text>During bristle development, the lateral inhibition competition is 
rigged by asymmetric localization of Numb protein.</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>Morphogen: A signaling molecule that imposes a pattern on a field 
of cells. This means that the morphogen induces different responses 
depending on its concentration. 
Gradient of inducer extending across a field of cells 
Cell type A Cell type B Cell type C Cell type D Cell type E Cell type F 
Source of 
inducer</text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>Hair cells always 
occur in a mosaic 
with supporting 
cells</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text>-----------Gallus gallus (Chick) Limb Development-Retinoic Acid and Sonic 
Hedgehog (SHH) 
To the left is a chick embryo (sans shell) with normal wing development. 
Courtesy of Dr. Fallon, Univ. of Wisconsin 
Courtesy of Dr. Tickle, Univ. of Dundee A bead soaked in Retinoic Acid was implanted into the 
anterior margin of the early wing limb-bud. Note the mirror-image duplication of the digits. 
IV	 ZPA graft can beIII 
II	 mimicked by 
implantation ofII 
III a bead soaked 
IV in retinoic acid 
Digit IV represents a posterior limb structure. The ectopic release of Retinoic Acid from the bead leads to 
ectopic expression of Sonic Hedgehog (SHH) , forming a secondary ZPA.</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 2.1 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_genetic_hearing_loss/</lecture_pdf_url>
      <lectureno>9</lectureno>
      <slides>
        <slide>
          <slideno>28</slideno>
          <text>Gene Discovery Methods
Genetic Linkage 
Pedigree analysis of isolated populations 
Tissue Specific Approaches 
Inner ear cDNA libraries 
Microarray expression profiling 
Model System Approaches
Mouse, fly, fish</text>
        </slide>
        <slide>
          <slideno>37</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>30</slideno>
          <text>DFNB17 family from the Madras region of India
See American Journal of Medical Ge netics 78:107113 (1998), Grienwald et al.</text>
        </slide>
        <slide>
          <slideno>32</slideno>
          <text>Human-Mouse Homology Map
See Molecular Biology of the Cell, Vol. 4, Alberts et al.</text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>40</slideno>
          <text>deaf vs. Deaf</text>
        </slide>
        <slide>
          <slideno>35</slideno>
          <text>hDIAPH SSCP analysis and expression profile
See Lynch et al., Science 1997, 27b:1223</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>39</slideno>
          <text>Risk of deaf offspring
	Mating type 
hearing x hearing 
hearing x deaf 
deaf x deaf % Deaf offspring 
0.1% 
7% 
10%</text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>Genetic hearing loss may be
 
 
	 Dominant, recessive, X-linked, 
mitochondrial, or chromosomal 
	 Congenital or have a post-natal onset 
(prelingual or postlingual) 
 Stable or progressive 
 Conductive, sensorineural or mixed 
 An isolated finding or part of a syndrome</text>
        </slide>
        <slide>
          <slideno>24</slideno>
          <text>Deafness Environmental 
Genetic ~50% 
30% 
70% ~50% Syndromic 
Alport 
Pendred Waardenburg 
Branchio-Oto-Renal 
Jervell and Lange Nielsen Usher Norrie 
~15% 
~80% 
~3% 
~2% Non-syndromic 
Autosomal Recessive 
(DFNB1-DFNB30) 
X-Linked 
(DFN1-DFN8) 
Mitochondrial Autosomal Dominant 
(DFNA1-DFNA39) 
Jan2001</text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text>Clinical characteristics of the 
 
Type I
 
Type II
 
Type III 
Usher syndromes
 
Hearing Vestibular 	 Vision Min. # # genes 
loss loss genes Idd 
congenital 
 absent onset 1st 7 3 
profound 
 decade 
congenital normal onset 1st 3 1 
sloping or 2nd 
decade 
progressive 
 variable
 variable 1 0</text>
        </slide>
        <slide>
          <slideno>34</slideno>
          <text>See Leon et. al, Proceedings of the National Academy of Science, 89 (1992)   C. National Academy of Sciences.</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>36</slideno>
          <text>Mutations in the DFNA1 genomic and cDNA sequences
See Lynch et al., Science 1997, 27b:1223</text>
        </slide>
        <slide>
          <slideno>25</slideno>
          <text>25 
36 
 24 
23
35 
34 
 22 
 26 
33 
DFNA2 DFNB9 16
 25
 21 
 DFNA6,14,38 15
24
 32 
 16 
 25
22
 DFNA24 23 
 24
 15 
14
 15 
 22 
 23
 21 
 23
 31 
 p 14 
 DFNB25 p 13
13 
 13 
 22 
p p pp 12 
22
 21
 15
12
 DFNA5 21
11 
14
22
 11
 12 
 21 
 DFNA13 p 13
 11 
 p 12
21 
DFNA27 14 
q 12 
 p DFNB6 q 13 
 12
11
 11 
 11
 12
 13
 DFNA3712
13
p 21
 p q q qq 12
 13 
 13 
 12 
11 
14 
 11 
q 22
 13
 14 
 13
 15 
 q 14 
 DFNA22 q 
24
 12
 21
 15
 21 
 21
12
 25 
 21
 16
 q 22
 22 
 26
 DFNB27 q 13
22
21 
 21
 23
 23 
 27 
 DFNB17 22
 21
 DFNA7 DFNA2822 
 24 
 DFNA16 22
 31
 28 
 DFNB4 DFNA1 22 
 DFNA10 DFNA18 23 
 31 
24 
23
31
 32 
 DFNB14 23 
DFNA15 23
 24 
 DFNB26 32
 DFNB15 31
25 
 33 
 DFNB13 24 
25
 32 
 33 
 24
35
 32
34
 31 
 25
 33
 33 
 26
 36
35
 26
 34
34 
27
 27
 35 
 DFNA24 8
 32 
 35
 28 
36 
 29 
41 
 6 7
37
42 
 5
3 4
43 
DFNA34 44 
2
1
15 
23 
24 
13 
22 
15
 14
 DFNA32 
13 
 13
 13
21 
13
 DFNB30 14 
 p p 12 p 12 12
 p 12 
 DFNB18 p 12 
p	 11
 11 
 11
 13 
12 
13 
 11
 13
11 
12 
 12
 DFNA19 p 
11 
p 12
11 
12 
 12 
q 13 
DFNA26 DFNA3/B1 DFNB5 12
 q 13 
 11
 q DFNB23 12 
13
 q DFNA9 q 14 
15
 q 14
 14
13 
 DFNB12 q 12 
21 
 11.2 DFNB7,11 21 
21
 15
 DFNB16 13 
 DFNA23 21 
 DFNA11/B2 21 
 22
 q 13
22
 DFNA36 22
 21 
 23
 21 
22 
DFNA25 22
 14 
23
 22
 21
 24
 22
 23
 24
 DFNA8,12/B21 23 
31 
22 
 31
23
24 
 25
 31
 24
 32
32 
23 
 DFNB24 24 
26
 33
 33 
 32
 25
 DFNA30DFNA41 34
 24
34 
 DFNB20 26
 25 
 16
13 14 15 
9 10 11 12 
22.3 DFN6 
22.1 
21 
 DFN413 
p 11.4 p 11.3 12 
 p 13.3 13 
 13 
 13
 11 
 11.2 DFNB19 p 13.2 p p 11.3 p 11.2 DFNB3 12
 DFNB15 p 12
13.1 11.2 11.211 
 11.2 
q 21 
12 
13
 q 12 
 11.2 
22 
12 
 q 21 
qq 13.1 DFNA17 21
 q 12
 21 
 DFNB29 q 12 
DFN3 q 
DFNA4 22 
24 
23 
 13.2 DFNB28 13.2 13.3 DFNB8,10 13 
22 
 22 
 DFN2 12 
25 
 13.4 DFNA20 23
23 
24
 DFNA26 25 
Y 
27
 17 18 19 20 21 22 26 
28 
January, 2002 X</text>
        </slide>
        <slide>
          <slideno>31</slideno>
          <text>Figure 1. Haplotype analysis showing selected markers in the Palestinian DFNB10 
family (BT117) 
See Berry, et al, Genomics 68, 2229 (2000)</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>http://www.people.virginia. edu/~rjh9u/gif/deafmute.gif</text>
        </slide>
        <slide>
          <slideno>41</slideno>
          <text>Additional Readings 
Lynch et al., Science 1997, 27b:1223</text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>Syndromic Hearing Loss
 
Syndrome
 Gene 
 
Alport 
 COL4A5, COL4A3, Col4A4 
 
Branchio-Oto-Re nal
 EYA1
 
Crouzon 
 FGF 
 
Jerve ll and Lange-Niels en
 KCNQ1, KCNE 1/IsK 
 
Mitochondrial (M ELAS , MERRF) 
 tRNAleu(UUR ),tRNAlys
 
Neurofi bromatos is type II
 NF2 
 
Norrie 
 NDP 
 
Osteogenesis Imp erfecta 
 COL1A1, COL1A2 
 
Pendred 
 PDS 
 
Stickle r
 COL2A1, COL11A2, COL11A1 
 
Tran ebjaerg-Mohr (DFN1 )
 DDP 
 
Treacher Co llins 
 TCOF1
 
Usher 
 MYO7 A, USH2A, USH1C, CDH23 
 
Waardenbur g 
 PAX3, M ITF, EDNRB , EDN3, SOX10</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>Obstacles to Studying Genetic 
 
 
Deafness
 
 
 Inaccessible to direct observation 
 Located in the densest bone in the body 
 Pathological studies are often much delayed 
 Unparalleled genetic heterogeneity 
 Deaf x deaf matings due to linguistic 
homogamy</text>
        </slide>
        <slide>
          <slideno>38</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>21</slideno>
          <text>Mitochondrial Deafness
 
 Syndromic - systemic neuromuscular 
syndromes, diabetes &amp; deafness, PPK &amp; 
deafness 
 Nonsyndromic - A1555G 12S rRNA 
A7445G tRNAser 
 Ototoxic - A1555G (12S rRNA)</text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>PAX3 at 2q35
 
See Ishikiriyama et al., 1989</text>
        </slide>
        <slide>
          <slideno>23</slideno>
          <text>Deafness Modifier Genes
 
	 moth1 mutations prevents/worsens tubby mouse 
deafness (Ikeda et al . 1999) 
	 mdfw mouse locus prevents/worsens deafwaddler 
deafness (Noben-Trauth et al. 1997) 
 A nuclear locus causes A1555G mitochondrial 
deafness in absence of aminoglycosides (Bykhovskaya 
et al. 2000) 
	 DFNM1 locus prevents DFNB26 deafness
(Riazuddin et al. 2000)</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>22</slideno>
          <text>Modifier Genes of Deafness
 
	 Modifier gene: a particular allele of one gene affects the 
expression of a second gene and thereby modifies the 
phenotype 
	 Affect the age of onset, progression, severity, or 
penetrance of hearing loss 
	 May mediate normal or abnormal function; can prevent or 
worsen the hearing loss caused by the second gene</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>Cx26</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text>The Usher Syndromes
 
	 C.H. Usher documented the association of 
deaf/blindness and its inheritance in an 
autosomal recessive fashion in 1914 
	 ~50% of the deaf/blind population has 
Usher syndrome 
	 Type I Usher Syndrome is three times more 
common than type II or III</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>Prevalence of Hearing Impairment
 
 28 million Americans 
 2 million profoundly deaf 
 1/1000 congenitally deaf 
 1/3 impaired by age 65 
 1/2 impaired by age 80 
NIDCD National Strategic Research Plan, 1989</text>
        </slide>
        <slide>
          <slideno>33</slideno>
          <text>.AGATGAGCA..
.AGATTAGCA..Gene/Mutation Identification
1 2 3 4 5 6 7 8 
9 10 11 12 13 14 15 16 
17 18 19 20 21 22 X Y 1) Family Discovery and 
Pedigree Construction 2) Linkage Analysis 
Connexin 26 Gene 
13 SAP18 SGCG 
FGF9 GJB2 
DFNB1 
.. 
.. 
Hearing 
Deaf 
4) Mutation Analysis 
3) Positional Cloning</text>
        </slide>
        <slide>
          <slideno>27</slideno>
          <text>Autosomal Recessive
nonsyndromic hearing loss tends to be:
prelingual, stable, affecting all frequencies
Autosomal Dominant
nonsyndromic hearing loss tends to be:
postlingual, progressive, affecting a subset 
of frequencies</text>
        </slide>
        <slide>
          <slideno>26</slideno>
          <text>Nonsyndromic
 
Deafness
 
Genes
 
Cloned
 Locus  Gen e (Protein) Cl oned 
DFN3 POU3F4 (POU3F4) 1995 
DFNB1/A3 GJB2  (connexin 26) 1997 
DFNA 11/B2 MYO7A ( myosin VIIA ) 1997 
DFNA 1 DIAPH1  (diaphanous 1) 1997 
DFNB4 PDS (pendrin) 1997 
Near  DFNA2 GJB3 (connexin 31) 1998 
DFNA 5 DFNA5  (DFN A5) 1998 
DFNA 9 COCH (COCH) 1998 
DFNA15 POU4F3 (POU4F3) 1998 
DFNB3 MYO15 (myosin X V) 1998 
DFNA8/A12/B 21 TECTA (-tectorin) 1998 
Near  DFNA2 KCNQ4  (KCNQ4) 1999 
DFNB9 OTOF  (otoferlin) 1999 
Near  DFNA3/B 1 GJB6  (connexin 30) 1999 
DFNA13 COL11A2  (collagen type X I 2) 1999 
DFNB8/B10 TMPRSS3  (serine protease 3) 2000 
DFNA10 EYA4 (EYA4) 2000 
DFNB29 CLDN1 4 (claudin-14) 2000 
DFNA17 MYO9 (myosin IX ) 2000 
DFNB12 CHD 23 (cadher in-23) 2001</text>
        </slide>
        <slide>
          <slideno>29</slideno>
          <text>DFNA1 pedigree 
See Lynch et al., Science 1997, 27b:1223</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 2.1 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_intro_molec_biol_lect_2/</lecture_pdf_url>
      <lectureno>2</lectureno>
      <slides>
        <slide>
          <slideno>2</slideno>
          <text>See: Molecular Biology of the Cell, Alberts et al., 4th Edition</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>See: http://www.pitt.edu/~biohome/Dept/Img/graphics/grabowski/altsplice.jpg</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text>Organism Number of 
predicted 
genes % of Genome 
that encodes 
proteins 
E. coli 
(bacteria) 5,000 90% 
S. cerevisiae 
(yeast) 6,000 70% 
C. elegans 
(worm) 18,000 27% 
D. melanogaster 
(fly) 14,000 20% 
A. thaliana 
(plant) 25,500 20% 
Homo sapiens 
(human) 35,000 &lt; 5% 
Adapted from www.ebi.ac.uk/microarray/ biology_intro.htm</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>Gene expression differences
Ubiquitous expression
house-keeping genes
Genes expressed at 
relatively constant levels 
in nearly all cell types 
Proteins often involved 
in cell metabolism Differential gene expression
Genes expressed in a subset of cell types (tissue specific) 
OR only at certain times 
(developmental, regulated) 
Proteins often have very 
specialized functions</text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>Alba: A genetically engineered white rabbit that glows in the dark
http://abcnews.go.com/media/OnAir/images/ho_alba_green_000918_h.jpg</text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text>Charles Darwin 
1809 - 1882</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>This page is part of The Genetics of Cancer resource center, created and maintained by Eugene Pergament, MD, PhD, Northwestern University Medical 
School, Chicago, and Morry Fiddler, PhD, School for New Learning, DePaul University, Chicago.</text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>Human-Mouse Homology Map
See: Molecular Biology of the Cell, Vol. 4, Alberts et al.</text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>Gene expression differences
Ubiquitous expression
house-keeping genes
Genes expressed at 
relatively constant levels 
in nearly all cell types 
Proteins often involved 
in cell metabolism Differential gene expression
Genes expressed in a subset of cell types (tissue specific) 
OR only at certain times 
(developmental, regulated) 
Proteins often have very 
specialized functions</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>GJB2: Gap junction protein, beta 2, 26kD (connexin 26)
head_neck;skin; colon;ear, cochlea; brain; stomach; 
lung;ovary, epithelium;human eye anterior 
segment;esophagus;germ cell; uterus; nervous tumor; 
kidney; pool, liver+spleen; pancreas, exocrine; 
leiomios; pooled colon, kidney, stomach; bladder; testis; whole embryo;ovary; uterus, pooled; uterus, 
epithelium; heart; hepatocellular carcinoma; prostate; 
colonic mucosa with ulcerative colitus</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text>TECTA: Tectorin alpha
brain; testis; ear, cochlea</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text>Additional Readings 
Molecular Biology of the Cell, Vol. 4, Alberts et al.</text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>Sites of Noggin Gene Expression
See Brunet, L. J., McMahon, J. A., McMahon, A. P., Harland, R. M. (1998) Science . 280, 1455-1457.</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>.CGCCATGCTATCGAGCATCGTGCGAGCAGCGATGCGATGCT 
AGTAGCTGAGCGCTAGGCTAGCAGTCGCGTAGTCTAGCGACT 
AGTGCGACGTACGGCGCGCTAGAGTCGGCTATATCGGAGCGG 
GCGCGATTATATATGCGATGAGAAGCGGCCGGCGCGCGCGCG 
ACTGATCTATCTAGCATATCGATCTTCTCTAATCGCGCATGCG 
ATGCTAGCTGAGCGATCGGACGTAGCGACGGACGATATTATA 
TATTCGCGCGGCAGCGGCGCGGCTATATTTATATATTATATAT 
TATTATATTAGCGAGCTCTCGATTCTTATATATATAGCATCTGA
GCTGAGCGTATCAGTGCTAGCTGATGCTGTAGTCGATCGTAGC
ATTATATATATATATTATAGCGATCGGCGCGCGCGCGCGATCG
TAGCTGCTGTGTGTGTCAAAGCGATTCTATATATATTTTCGAG 
CTAGGAGCGCGGCGCCCCGATGCTCGAACTAGCGAGCTGAGC 
GACGAGCGAGCGACGGCGACTAGGCAGGCAGCGAGCTATTAA 
TTTATTAGCGACGCTAGTCGAAAATACGAGGCGCGCGCCATA 
CGGATTACGCTAGCGATTATGGGCCCCGGCGCGCGTAGCTGCT
GATGCTGTCGTGTGATCGGTGATGCGAGCGCGGCCGCGGCGG
CGCGATGTAGCTGATCGTAGTGTATGCGCGCGCGTAGCTTTAT
ATCGTAGTGCTCGTGTGACACACACACGATCGTAGCTGATCGA
TGCACCATGCTAGCAGCTACGTTGCGATCGCGCTAGCTAG..</text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>GAPDH: Glyceraldehyde-3-phosphate dehydrogenase
skin; brain; lung; lymph; ovary; placenta; uterus; breast; stomach; eye; colon; kidney; testis; 
pancreas; cervix; liver; prostate; b-cells; marrow; salivary gland; heart; muscle; head_neck; eye, 
retina; colon; adrenal gland; lymph, t-cell; chondrosarcoma; fetal pancreas; leiomios; brain, 
hippocampus; kidney_tumor; breast cancer; aorta,endothelium; bladder_tumor; osteoarthritic 
cartilage; prostate_normal; hepatocellular carcinoma; bone; epid_tumor; gall bladder; bladder;  
lens; foreskin, melanocyte; pooled colon, kidney, stomach; thymus; lung metatastic 
chondrosarcoma; placenta_normal; uterus_tumor; whole embryo; uterus; nervous_normal; testis, 
cell line; fibrosarcoma; brain, pituitary gland; b cells from burkitt lymphoma; ovary; blood; 
cartilage; lung, neuroendocrine lung carcinoids; pancreas, islet; adipose, white adipose tissue; 
brain, amygdala; retina; larynx; lung epithelial cells; trabecular meshwork; rpe and choroid; 
testis, epididymus; pancreas, exocrine; colon; spleen; retina; bone marrow stroma; prostate, 
epithelium; head_normal; omentum; pituitary; muscle, skeletal muscle; uterus, epithelium; lung 
with fibrosis; eye anterior segment; ear, cochlea; placenta; bone, synovia; pooled pancreas and 
spleen; lymph, b-cell; bone, trabecular bone cells; prostate, metastatic prostate;  bone lesion; 
tonsil, germinal center b-cells; brain, pineal gland; lung_tumor; brain, cerebellum; muscle 
(skeletal); breast_normal; germ cell; amnion_normal; sympathetic trunk; esophagus; brain, 
hippocampus ; testis_normal; muscle, striated; pnet; umbilical cord, endothelium; hypothalamus; 
cord blood; lung, cell line; parathyroid; tongue; uterus, endometrium; nervous_tumor; bone marrow; non cancerous liver tissue; whole blood; brain; fetal brain; colon_normal; synovial 
membrane; optic nerve; head and neck; umbilical cord vein, endothelium; fetal eye; brain, 
miningioma; aorta; lymph node; leukocyte; foveal and macular retina; connective tissue; 
placenta; brain, pituitary; genitourinary tract; eye, ciliary body; lung; prostate tumors ; skin, 
melanocyte; brain, astrocytoma; nose, olfactory epithelium; thyroid; blood, lymphocyte; germ</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 3.1 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_stem_cells_dec9sh/</lecture_pdf_url>
      <lectureno>22</lectureno>
      <slides>
        <slide>
          <slideno>9</slideno>
          <text>Embryonic development: Marker genes can reveal cell types 
Ectoderm Otic placode Otic vesicle Sensory patches hair cells 
Embryoid bodies 
(Ectoderm, Endoderm, 
Mesoderm) 
Factors that 
promote 
selective 
survival of otic progenitors 
Cell types of the otic placode: 
cells that express placode markers</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>What is next:
a) Are the hair cell-like cells really hair cells? 
b) Are these cells able to integrate into a developing ear? 
c) Are these cells able to integrate into an injured ear? 
d) Can we heal a deaf mouse with these cells?</text>
        </slide>
        <slide>
          <slideno>11</slideno>
          <text>Myosin VIIA
Pv3
F-actin</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>Embryonic development: Marker genes can reveal cell types 
Ectoderm Otic placode Otic vesicle Sensory patches hair cells</text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>21</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>23</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>Stem cell: 1) They can make identical copies of themselves 
(long-term self renewal). 
2) They can give rise to mature cell types with 
characteristic morphologies and functions. 
Embryonic stem cells: 	 originate from the inner cell mass 
of the blastocyst. 
Adult stem cells:	 Reside in organs and can replace 
cells that die because of injury 
or disease; they are rare: for example 
only 1 in 10,000 cells in the bone 
marrow is a hematopoietic (blood -
forming) stem cell.</text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text>Myosin VIIA</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>Embryonic development: Marker genes can reveal cell types 
Ectoderm Otic placode Otic vesicle Sensory patches hair cells 
ES cells 
Embryoid bodies 
(Ectoderm, Endoderm, 
Mesoderm)</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text>Adult stem cells 
Hair cells Inner ear stem cells? 
Progenitor cells</text>
        </slide>
        <slide>
          <slideno>24</slideno>
          <text>Further Reading
From Groves and Bronner-Fraser, 2000</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text>Embryonic stem cells (ES cells) 
 easy to getStem cells  easy to maintain 
 a long way from 
ES cell to hair cell 
The nave 
goal Mimic ear development 
Hair cells</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>19</slideno>
          <text>Elimination of the 
auditory ganglion 
with a neurotoxin -
followed by repair 
with progenitor cells 
selected from ES or 
adult stem cells. 
A) TypeII collagen
B) TypeII collagen 
after elimination 
C) Homogenin after 
elimination 
D) Coch 
after elimination 
=&gt; No change in other 
cell types.</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text>A permanent source for adult stem cells:
Adult stem cells from the skin
Inner ear progenitor cells 
Hair cells</text>
        </slide>
        <slide>
          <slideno>20</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text>Are there adult stem cells in the inner ear?
	Hair cell regeneration happens to a small degree in the mouse utricle 
(Forge et al., 1993, Science 259)</text>
        </slide>
        <slide>
          <slideno>22</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text>MARKER GENE 
Otx2 
Pax2 
Sox3 
BMP4, BMP7 
Hmx3 Nkx5-1, Nkx5-2 
Sox10 
Math1 
Notch1 
Delta1 
Jagged1 Jagged2 
Brn3.1 
Pv3 Myo VIIA 
Espin 
AchR D9, D10 
Mehc1 
Tmc1 
Cx26 
TectA 
Coch 
Pax6 
Nestin 
NCAM 
GAPDH Collection of inner ear marker genes 
EXPRESSION 
undifferentiated ES cells, neuroectoderm, otic vesicle 
otic placode, developing midbrain, hindbrain, and eye 
otic placode early 
otic placode, otic vesicle markers developing vestibular inner ear 
developing inner ear non-sensory epithelia, nascent stria vascularis 
otic vesicle, developing inner ear sensory epithelia, supporting cells 
developing inner ear sensory epithelia 
otic vesicle, developing inner ear sensory epithelia 
developing inner ear sensory epithelia, nascent hair cells 
developing inner ear sensory epithelia, supporting cells 
developing inner ear sensory epithelia 
developing inner ear sensory epithelia, mature hair cells 
early hair cells, mature hair cells 
otic vesicle, olfactory epithelium, retina, hair cells 
hair cells, Sertoli cells 
cochlear and vestibular hair cells 
inner hair cells, mature photoreceptor cells 
hair cells lateinner ear non-sensory cells, skin 
developing inner ear markers 
inner ear fibrocytes 
developing eye, developing central nervous system 
Neuronal progenitors 
Neuronal progenitors 
ubiquitously expressed housekeeping gene</text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>Principal strategy In neural stem cell world, this 
would be called a neurosphere 
Mouse utricle Low density Sphere formation 
single cell culture 
Selection of 
progenitor cells 
Hair cells and supporting cells 
by in vitro 
differentiation 
Immunostaining for the 
progenitor 
cell marker nestin in neural 
stem 
cells (C) and in 
inner ear spheres (D)</text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text>Inner ear stem cells? 
Adult stem cells 
Progenitor cells
Hair cells</text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text>What is next:
a) Are the hair cell-like cells really hair cells? 
b) Are these cells able to integrate into a developing ear? 
c) Are these cells able to integrate into an injured ear? 
d) Can we heal a deaf mouse with these cells? 
e) Can we generate other cell types as well? 
For example auditory neurons:
Do these neurons (re-)innervate a cochlea?</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
    <lecture>
      <lecture_title>PDF - 1.8 MB</lecture_title>
      <lecture_pdf_url>https://ocw.mit.edu/courses/hst-730-molecular-biology-for-the-auditory-system-fall-2002/resources/new_lab_introsept25_sh/</lecture_pdf_url>
      <lectureno>3</lectureno>
      <slides>
        <slide>
          <slideno>11</slideno>
          <text>Step 4. Transformation of E. coli K-12 with the ligation products. 
See Applied Molecular Genetics, R. Mies feld, Wiley Publishing, New York, 1999.</text>
        </slide>
        <slide>
          <slideno>6</slideno>
          <text>Plasmids 
(cloning vectors) 
Most of the domains or fragments that are used in cloning vectors
originated in naturally occurring vi rulence and resistance plasmids.</text>
        </slide>
        <slide>
          <slideno>8</slideno>
          <text>Design of a cloning vector:
1) origin of autonomous replication 
(ori, ColE1 ori) 
2) A genetic marker for selection 
(beta-lactamase gene = ampR) 
3) Unique restriction sites 
(MCS) 
4) Minimum amount of 
nonessential DNA
ori AmpR 
EcoRI 
HindIII 
XhoI 
ori AmpR BamHI 
EcoRI, BamHI, HindIII, XhoI</text>
        </slide>
        <slide>
          <slideno>17</slideno>
          <text>Practical part:	 Analysis of four cDNA clones randomly selected from a chicken late embryonic 
cochlea sensory epithelium cDNA libr ary 
Day 1 (Lecture #3): 	 Inoculation of 4 overnight cultures (16hr growth) of plasmid-bearing E. coli XL- 1 blue. 
Day 2 (Lecture #4): 	 Harvesting of the bacteria by ce ntrifugation and storage of the cell pellets a t -80C 
Day 3 (Lecture #5)	 DNA preparation (4 samples) 
Absor ption measurement at 260nm to determine the DNA concentration 
Sample preparation for automated DNA sequencing 
Day 4 (A day before Lecture #6): Sa mple submiss ion for DNA sequencing 
Day 5 (Lecture #7) :	 DNA rest riction digest 
Agarose gel electrophoresis 
Hand-out of the sequencing results 
Your job: A) Find as much information as possible about your clones. 
Remember that the clones stem from an anim al model. Why is the chicken an appropriate 
animal model for inner ear gene discover y? What are disadvantages of the chicken model? 
Pick one or two clones that ma y have significance f or inner ear function. What is know n 
about these genes? 
B) Document your experiments in a way that someone else could repeat them without 
having any further information.</text>
        </slide>
        <slide>
          <slideno>13</slideno>
          <text>The Four basic steps in constructing a cDNA library:
1. Purification of mRNA using chemical extraction and oligo-dT purification. 
2. First strand cDNA synthesis using oligo-dT, random pdN6, or specific primers. 
3. Second strand cDNA synthesis requires a priming event; done with RNaseH. 
4. Repair of cDNA termini and ligation of adaptor oligos ; clone into vector.</text>
        </slide>
        <slide>
          <slideno>16</slideno>
          <text>500 chicken cochlear ducts (enriched sens ory epithelium) - embryonic days 14-19 
100 g total RNA 
5 g polyA+ RNA (mRNA) 
First strand cDNA synthesis 
Second strand cDNA synthesis 
Adapter ligation 
pAD-Gal4 [EcoRI/XhoI] 
cDNA library in pAD-Gal4 
5 x 106 independent cDNA clones in pAD-Gal4 
amplification (transformation into E. coli and 
selection with ampicillin -&gt; plasmid preparation 
See Applied Molecular Genetics, R. Mies feld, Wiley Publishing, New York, 1999.</text>
        </slide>
        <slide>
          <slideno>4</slideno>
          <text>Major Steps in the Development of Recombinant DNA andTransgenic Technology 
1869 Miescher first isolates DNA from white blood cells harvested from pus-soaked bandages obtained  from a nearby hospital.
1944 Avery provides evidence that DNA, ra ther than protein, carries the genetic information during bactetransformation. 
1953 Watson and Crick propose t he double-helix model for DNA structure based on x-ray results of Franklin and Wilkins.
1955 Kornberg discovers DNA polymerase, the enzym e now used to produce labeled DNA probes.
1961 Marmur and Doty discover DNA renaturati on, establishing the specificity and feasib ility of nucleic acid  hydridization react ions.
1962 Arber provides the first ev idence for the existence of DNA restriction nucl eases, leading to their purification and use in
DNA sequence characterizati on by Nathans and H. Smith. 
1966 Nirenberg, Ochoa, and Khor ana elucidate the genetic code. 
1967 Gellert discovers DNA li gase, the enzyme used to jo in DNA fragments together. 
1972-1973 DNA clon ing techniques are developed by the laboratories of Boyer, Cohen,  Berg, and their colleagues at 
Stanford University and the University  of California at San Francisco. 
1975 Southern develops ge l-transfer hybridization for the detection of specific DNA sequences. 
1975-1977 Sanger and Barrell and Maxam and Gilbert dev elop rapid DNA-se quencing methods. 
1981-1982 Palmiter and  Brinster produce transgenic mice; Spradlin g and Rubin produce tr ansgenic fruit flies. 
1982 GenBank, NlH's public  genetic sequence database,  is established at Los Al amos National Laboratory. 
1985 Mullis and co-workers invent t he polymerase chain reaction (PCR). 
1987 Capecchi and Smithies introduce methods for performing targeted gene replac ement in mouse embryonic stem cells. 
1989 Fields and Song develop the yeast two-hybrid system  for identifying and study ing protein interactions. 
1989 Olson and colleagues describe sequence- tagged sites, unique stretches of DNA that are used to make physical maps 
of human chromosomes. 
1990 Lipman and colleagues rel ease BLAST, an algorithm used to search for homology betwee n DNA and protein sequences. 
1990 Simon and colle agues study how to efficiently use bacterial artificial chromosomes, BACs, to carry large pieces of 
cloned human DNA for sequencing. 
1991 Hood and Hunkapillar introduce new au tomated DNA sequence technology. 
1995 Venter and colleagues sequence the first complete genome, that of the bacterium Haemophilus influenzae. 
1996 Goffeau and an internationa l consortium of researchers announce the completi on of the first geno me sequence of a 
eucaryote, the yeast Saccharomyces cerevisiae. 
1996-1997 Lockhart and colleagues and Brown and DeRisi produce DNA microarrays,  which allow the simultaneous 
monitoring of th ousands of genes. 
1998 Sulston and Waterston and colleagues produce the first complete sequ ence of a multicellular organisms, the nematode 
worm Caenorhabditis elegans. 
2001 Announcement of the completion of the draft human genome.</text>
        </slide>
        <slide>
          <slideno>14</slideno>
          <text>1. Purification of mRNA 
Since RNA is single-stranded, any hydrolysis event that br eaks the phosphate backbone will 
result in cleavage of the mole cule into subfragments. Two factors contribute to the biochemical 
instability of RNA. 
1. Endoribonucleases ( RNases ) are very stable enzymes that c annot be easily inactivated . In 
fact, human hands are a rich so urce of RNase and it is theref ore necessary to wear clean 
gloves during RNA isolation procedur es and to use RNase-free labware. 
2. RNA is thermodynamically le ss stable than DNA because of the 2 hydroxyl group on the 
ribose ring that promotes hydrophilic attack on the 5-3 phosphodiester bond to form a 2-3 
cyclic phosphate . This cyclic phosphate interm ediate is stabilized by Mg2+, a component of 
many biochemical reactions.</text>
        </slide>
        <slide>
          <slideno>0</slideno>
          <text>E. coli K12</text>
        </slide>
        <slide>
          <slideno>3</slideno>
          <text>Improvements of E. coli K12 for recombinant DNA methods:
 3) recA-mutation that suppresses homologous recombination and 
that makes it more sensitive to UV light. 
 4) Mutation in the endonuclease A gene (endA) that greatly improves 
the quality of DNA isolated with biochemical techniques. 
Genotypes 
XL1-Blue strain: 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F'proAB lacIqZM15 Tn10 (Tetr)]
XL1-Blue MR strain: (mcrA)183 (mcrCB-hsdSMR-mrr)173
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac
http://www.stratagene.com</text>
        </slide>
        <slide>
          <slideno>18</slideno>
          <text>Additonal Readings 
Applied Molecular Genetics, R. Miesfe ld, Wiley Publishing, New York, 1999.</text>
        </slide>
        <slide>
          <slideno>7</slideno>
          <text></text>
        </slide>
        <slide>
          <slideno>5</slideno>
          <text>Hogenesch et al. (2001), Cell 106: 413-415</text>
        </slide>
        <slide>
          <slideno>9</slideno>
          <text>A typical plasmid cloning strategy involves five steps :
1) Enzyme restriction digest of DNA sample.
2) Enzyme restriction digest of DNA plasmid vector.
3) Ligation of DNA sample products and plasmid vector.
4) Transformation of E. coli K-12 with the ligation products. 
5) Growth on agar plates with selection for antibiotic resistance.
See Applied Molecular Genetics, R. Mies feld, Wiley Publishing, New York, 1999.</text>
        </slide>
        <slide>
          <slideno>2</slideno>
          <text>Improvements of E. coli K12 for recombinant DNA methods:
 2) Removal of the mcrA/mcrB genes that are responsible for 
degrading foreign DNA that is methylated, but not at 
the sites that E. coli K12 would recognize as its own. 
(For example human and mouse DNA: CpG-methylated) 
http://www.biochem.arizona.edu/classes/bioc471</text>
        </slide>
        <slide>
          <slideno>10</slideno>
          <text>Step 3 . Ligation of DNA sample products and plasmid vector 
See Applied Molecular Genetics, R. Mies feld, Wiley Publishi ng, New York, 1999.</text>
        </slide>
        <slide>
          <slideno>12</slideno>
          <text>Replication 
Transcription capping
Mutation polyadenylation
Transcription factors Translation
genomic DNA --&gt; --&gt; protein --&gt; --&gt;  primary transcript  mR NA  multiprotein complex 
RNA splicing 
postranslational modification 
protein targeting 
protein interactions 
protein turnover 
One of the milestones of molecular biology: 
cDNA (complementary  DNA)  &lt;--- mRNA 
Howard Temin and David Balt imore discovered that the viral RNA-encoded enzyme 
reverse transcriptase (RT) can synthesize DNA from mRNA templates.</text>
        </slide>
        <slide>
          <slideno>15</slideno>
          <text>--&gt; --&gt; mRNA (PolyA+ RNA) Chicken embryonic cochlea  To tal RNA purification  
First strand cDNA synthesis  -- &gt;  Second strand cDNA synthesis
Adapter ligation
5 3 
3 5 
G NNNNAAAAAAAAAAAAAAAAAAAAAAACTCGA
NNNNTTTTTTTTTTTTTTTTTTTTTTTGAGCTC GAATTCGGCACGAG 
GCCGTGCTC 
EcoRI adaptor XhoI restriction 
site</text>
        </slide>
        <slide>
          <slideno>1</slideno>
          <text>Improvements of E. coli K12 for recombinant DNA methods:
 1) Removal of the EcoK restriction system (hsdR-) 
http://www.biochem.arizona.edu/classes/bioc471</text>
        </slide>
      </slides>
      <videos/>
    </lecture>
  </lectures>
</doc>
